AC Immune S.A. (ACIU) vs Fate Therapeutics, Inc. (FATE)
A side-by-side comparison of AC Immune S.A. and Fate Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACIU
AC Immune S.A.
$2.71HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
FATE
Fate Therapeutics, Inc.
$2.43HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACIU vs FATE
growth of $100 · dividends reinvested · last 10yACIU -83.1% (-16.3%/yr)FATE -18.2% (-2.0%/yr)FATE compounded faster over this window
ACIU FATE
ACIU vs FATE: by the numbers
- •FATE is the larger company ($283M vs $276M market cap).
- •Both run net losses; ACIU's is the smaller (-249.94% vs -1941.09% net margin).
- •Both shrank revenue over the past five years; ACIU's decline was smaller (-23.70% vs -32.98% CAGR).
Metrics side by side
Valuation
| Metric | ACIU | FATE |
|---|---|---|
| P/S ratio | 12.71 | 43.64 |
| P/B ratio | 6.34 | 1.85 |
Profitability
| Metric | ACIU | FATE |
|---|---|---|
| Gross margin | 100.00% | -94.12% |
| Operating margin | -1927.32% | -2222.45% |
| Net margin | -249.94% | -1941.09% |
| ROE | -124.67% | -82.12% |
| ROIC | -89.43% | -58.72% |
Growth (annualized)
| Metric | ACIU | FATE |
|---|---|---|
| Revenue CAGR (5Y) | -23.70% | -32.98% |
| Total return CAGR (5Y) | -16.03% | -46.86% |
Frequently asked
- Which has grown faster, ACIU or FATE?
- Neither grew: over the past five years both shrank revenue, with ACIU's decline the smaller — ACIU at a -23.70% CAGR versus FATE at -32.98%.
- How have ACIU and FATE total returns compared?
- Over the past 10 years, ACIU delivered -16.61% and FATE delivered -2.31% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.